A Potent And Specific CD38 inhibitor ameliorates age-related metabolic dysfunction by reversing tissue NAD+ decline
BPC-157 and Thymosin Beta 4 emerged as important subjects of investigation due to their unique peptide structures and broad relevance within experimental biological research
Cohen SA, Kasi PM, Aushev VN, Hanna DL, Botta GP, Sharif S, Georgios I Laliotis MD, PhD, Sharma VR, Alqahtani A, Chandana SR, Kang S, Chakrabarti S, Somer BG, Kasi A, Dayyani F, Malla M, Jurdi AA, Liu MC, Aleshin A, Kopetz S
J Clin Endocrinol Metab 81:33523359 Vaccarello MA, Diamond FB Jr, Guevara-Aguirre J, Rosenbloom AL, Fielder PJ, Gargosky S, Cohen P, Wilson K, Rosenfeld RG (1993) Hormonal and metabolic effects and pharmacokinetics of recombinant insulin-like growth factor-I in growth hormone receptor deficiency/laron syndrome
Cho kh nng tc ng ni sinh, ngha l L-Glutathione s c hp thu vo mu v lan ta ti ton b lp da
doi: 10.3390/cimb46120807